within Pharmacolibrary.Drugs.C_CardiovascularSystem.C09B_AceInhibitorsCombinations.C09BB07_RamiprilAndAmlodipine;

model RamiprilAndAmlodipine
  extends Pharmacolibrary.Drugs.ATC.C.C09BB07;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>C09BB07</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Ramipril is an angiotensin-converting enzyme (ACE) inhibitor and amlodipine is a dihydropyridine calcium channel blocker. This fixed dose combination is used for the treatment of hypertension and/or cardiovascular risk reduction. Both drugs are widely approved and in current clinical use.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for orally administered ramipril and amlodipine in adults based on the known PK profiles of each agent in healthy subjects.</p><h4>References</h4><ol><li><p>He, YL (2012). Clinical pharmacokinetics and pharmacodynamics of vildagliptin. <i>Clinical pharmacokinetics</i> 51(3) 147–162. DOI:<a href=&quot;https://doi.org/10.2165/11598080-000000000-00000&quot;>10.2165/11598080-000000000-00000</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/22339447/&quot;>https://pubmed.ncbi.nlm.nih.gov/22339447</a></p></li><li><p>Ferri, N, &amp; Corsini, A (2025). [Clinical pharmacology of combination therapies for the prevention and treatment of cardiovascular diseases]. <i>Giornale italiano di cardiologia (2006)</i> 26(1 Suppl 2) e6–e16. DOI:<a href=&quot;https://doi.org/10.1714/4425.44225&quot;>10.1714/4425.44225</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/39898749/&quot;>https://pubmed.ncbi.nlm.nih.gov/39898749</a></p></li><li><p>He, YL, et al., &amp; Howard, D (2008). Vildagliptin, a novel dipeptidyl peptidase IV inhibitor, has no pharmacokinetic interactions with the antihypertensive agents amlodipine, valsartan, and ramipril in healthy subjects. <i>Journal of clinical pharmacology</i> 48(1) 85–95. DOI:<a href=&quot;https://doi.org/10.1177/0091270007307880&quot;>10.1177/0091270007307880</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/17986525/&quot;>https://pubmed.ncbi.nlm.nih.gov/17986525</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end RamiprilAndAmlodipine;
